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Summary Little is known regarding the prevalence and course of fatigue in cancer patients after treatment has ended and no recurrence
found. The present study examines fatigue in disease-free cancer patients after being treated with radiotherapy (n = 154). The following
questions are addressed. First, how do patients describe their fatigue 9 months after radiotherapy and is this different from fatigue in a non-
selective sample from the general population (n = 139)? Secondly, to what degree is fatigue in patients associated with sociodemographic,
medical, physical and psychological factors? Finally, is it possible to predict which patients will suffer from fatigue 9 months after
radiotherapy? Results indicated that fatigue in disease-free cancer patients did not differ significantly from fatigue in the general population.
However, for 34% of the patients, fatigue following treatment was worse than anticipated, 390o listed fatigue as one of the three symptoms
causing them most distress, 26% of patients worried about their fatigue and patients' overall quality of life was negatively related to fatigue
(r = -0.46). Fatigue in disease-free patients was significantly associated with: gender, physical distress, pain rating, sleep quality, functional
disability, psychological distress and depression, but not with medical (diagnosis, prognosis, co-morbidity) or treatment-related (target area,
total radiation dose, fractionation) variables. The degree of fatigue, functional disability and pain before radiotherapy were the best predictors
of fatigue at 9-month follow-up, explaining 30%/o, 3%0 and 4% ofthe variance respectively. These findings are in line with the associations found
with fatigue during treatment as reported in the preceding paper in this issue. The significant associations between fatigue and both
psychological and physical variables demonstrate the complex aetiology of this symptom in patients and point out the necessity of a
multidisciplinary approach for its treatment.
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Despite the high prevalence offatigue in cancer patients. there is a
lack of research on its causes and course oxer time. Studies
performed are mostly restricted to the period of treatment (Smets
et al. 1993). Consequently. little is known regarding the prevalence
and course of fatigue following treatment. However. results from
studies investigating psychological and physical distress in cancer
survivors sunCest that some patients continue to experience fatigue
long after treatment has ended. Devlen et al (1987). for example.
examined 120 newIly diagnosed patients with Hodgkin's or non-
Hodgkin's disease in a prospective study. Although most patients
were no longer receivinr treatment and were free of cancer at 1-
year follow-up. 42%7 of these patients continued to complain of
loss of energy and 32% of tiredness. Fobair et al (1986) investi-
gated the psychological problems that dexeloped in long-term
surxiv%ors of Hodakin's disease. At a median time since treatment
of 9 years. energy had not returned to their satisfaction in 37%7 of
the patients. In a surxey among members of the Dutch patient
organization of Hodgkin and non-Hodgkin patients (Breij and
Visser. 1990). 61%7 of the subjects reported fatigue that w-as
described as 'moderate to quite bad'. Treatment had ended more
than 2 vears before the sunrey in 60%e of the sample. Lastly.
Recefved 17 December 1997
Revised 17March 1998
Accepted 1 Apnl 1998
Correspondernce to: EMA Smets
Berglund et al ( 1991 ) assessed late effects ofadjuvant treatment of
breast cancer patients. free from recurrence 2-10 years after
primary therapy. Patients who had received radiotherapy reported
decreased stamina (75%7) more frequently than did chemotherapy
patients (61%).
The mechanisms contributing to persistent fatigue in disease-
free cancer patients can only be speculated upon. Permanent
changes in the immune or endocrine system. resulting, from treat-
ment toxicit'. might cause a person to feel more fatigued.
Treatment may also have resulted in permanent chanaes in phys-
ical functioning, such as chanaes in defecation pattern. in luna
function caused by fibrosis of lungy tissue or in hormonal func-
tioning (Leer and Van der Schueren. 1991). These in turn may
bring about symptoms such as pain or shortness of breath and
impairments in daily functioning, that in our study (see foreaoing
article) and other studies (Irvine et al. 1994: Belza. 1995) ha-e all
been found to be associated with fatiaue. Immobilization has also
been suacested as an explanation for persistent fatigue. Inactix ity
resulting from prolonged periods of bed rest reduces the capacity
for activity and produces an increased sense of effort for a
gixen level ofactivity (Sharpe and Bass. 1992). From apsycholog-
ical perspective. it is suggested that greater fatiguability resultincg
from an impaired condition micht induce axoidance behaviour
xhich. in the long, run. sustains feelinas of fatigue (Wessely et al.
1990). Chronic fatigue is also commonly found to be related to
feelings ofdepression or anxiety (Wessely et al. 1990: Ray. 1991:
Belza. 1995).
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The symptom of fatigue is not specific for cancer. Prevalence
rates between 14% and 34% of tiredness have been found in
community surveys (Chen. 1986: Rillsdale. 1991: Lewis and
Wessely. 1992: Bensing and Schreurs. 1995). In ambulatory care.
fatigue is one of the most frequently reported problems. For
example. Kroenke et al (1988) reported that of the 1159 patients
surveyed from primary care clinics 24% indicated that fatigue had
been a major problem for a month or more. In a study involving
randomly selected patients of a health care centre. 45% were
scored as fatigued (Valdini et al. 1987). More recently. Fuhrer and
Wessely (1995) noted in their primary care sample that about one-
third ofall patients reported persistent symptoms offatigue both in
a self-administered questionnaire and to theirphysician. Results of
a pnmary care study in the Netherlands indicate that fatigue is the
third most frequent reason reported forconsulting aprimary physi-
cian (van Boven and Dijksterhuizen. 1993).
To interpret the significance of results obtained in follow-up
studies involving cancer patients. a comparison should therefore
be made with persons without a history of cancer. Pickard-Holley
(1991) made such a comparison and did not find any difference
between a sample of 12 women receiving chemotherapy for
ovarian cancer and a convenience sample of 12 apparently healthy
women. Irvine et al (1994) compared fatigue in cancer patients
(n = 101) with fatigue in healthy auxiliary staff (n = 53). Before
the start ofeither radio- orchemotherapy treatment. no differences
between groups were found. However. over the course of treat-
ment. the degree of fatigue reported by patients was significantly
higher than fatigue reported by the control subjects. Finally. Glaus
(1993) compared the level of fatigue over 24-h periods of in-
patients with cancer (n = 20). in-patients with chronic inflamma-
tory gastrointestinal disease (n = 12) and healthy control subjects
(n = 30). The profile over the day showed significant differences
between these groups. In the morning, cancer patients had the
highest level offatigue compared with the other two groups. their
fatigue slowly increasing during the day. The healthy control
subjects started the day without tiredness. remained fit until the
late afternoon and became very fatigued in the evening. However.
when the fatigue scores were averaged over a 24-h period. no
significant differences between the groups were found.
These studies suffer from methodological weaknesses such as
small sample sizes. heterogeneity with respect to diagnosis and
treatment modality and/or the control groups being convenience
samples. Also. all studies were restricted to the period of active
cancer treatment.
This investigation examines fatigue in disease-free cancer
patients after having been treated with radiotherapy. The research
questions addressed are as follows. Firstly. how fatigued are
patients 9 months afterradiotherapy and how do they describe this
experience. Secondly. to what degree is fatigue in disease-free
patients associated with sociodemographic. medical and concur-
rent physical and psychological factors. Finally. is it possible to
predict before the start of radiotherapy which patients will suffer
from fatigue 9 months afterwards?
METHOD
Sample and procedure
Disease-free patients
Disease-free patients comprised consecutive cancer patients who
had finished radiotherapy at the Academic Medical Centre in
Amsterdam 9 months before and were disease free at the time of
measurement. Eligibility criteria and the procedure are described
in more detail in the preceding article in this issue. Patients were
excluded from the 9-month follow-up when they had received
additional cancer treatment following radiotherapy.
Reference group
The reference group consisted of a non-selective sample taken
from the telephone directories of the same residential areas from
which the patients were derived. A letter was sent to the selected
residences to introduce the study. which was followed by a tele-
phone call by the researchers. In order to prevent an overrepresen-
tation ofwomen. on the grounds ofbein, more frequently at home
when approached for participation. the next person to have a
birthday within that residence was asked to participate.
Respondents were to be at least 18 years ofage.
Out of practical considerations. most respondents were
requested to complete a home-sent questionnaire. To investigate a
possible bias introduced by the difference in method as compared
with the patients. a subgroup of respondents was invited to be
interviewed at their home.
Respondents who declined participation were asked to give
theirdate ofbirth and to rate theirfatigue on a scale from 0 to lO in
order to be able to assess selective drop-out.
Instruments
Disease-free patients
All standard instruments used in the disease-free patients were
similar to those described in the preceding article. Also. the same
information from their medical charts was used (diagnosis. prog-
nosis. radiation area and dose. fractionation). The following addi-
tional data were collected on interview: co-morbidity. the course
of fatigue since end of treatment. frequency of fatigue (never.
hardly ever. sometimes. most of the time or always), the time of
most intense fatigue during the day (no clear pattern. early
morning. noon. afternoon, late afternoon, evening). physical
sensations associated with fatigue (muscle weakness, sweating.
uncomfortable feeling in the chest. blurred sight and shortness of
breath: with response categories not at all. abit. moderate and very
much). hours of sleep, the degree of concern (not at all. a bit.
moderate, very much) and a comparison of their current fatigue
with fatigue during the previous month (less intense. no differ-
ence, more intense) and with theirexpectations (worse than antici-
pated, as expected. better than anticipated).
Reference group
Sociodemographic characteristics were recorded. Respondents
completed the Multidimensional Fatigue Inventory (MFI-20) and
the numerical scale for the assessment of fatigue. As in patients.
additional questions addressed the frequency of fatigue. the time
of most intense fatigue during the day. physical sensations associ-
ated with fatigue, hours ofsleep and perceived cause offatigue.
Statsical methods
Analyses involved descriptive statistics and one-way analyses of
variance (ANOVAs) for the description of fatigue. To establish a
possible effect of method of assessment in the reference group,
MFI scores for the interview and questionnaire groups were
compared using analyses of variance. As before. the score for
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Table 1 Sample charactenisbcs of disease-free patients (n= 154) and normal controls (n= 139)
Patents Controls
n % n %
Mean age (years) 65 +12 46 16a
Gender
Female 66 43 78 56a
Male 88 57 61 44
Education level
Less than high school 37 24 11 8
Lower educational level 48 31 34 24
High school 43 28 57 41
Advanced graduate degrees 26 17 35 25
Mantal status
Marmed 111 72 73 53
LMng together 6 4 15 11
Single 19 12 39 28
Widowed 18 12 10 7
(Co)-morbidity 74t 52 43 31
No. of patients with cancer diagnosis
Head and neck 8 5
Gastrointestinal 7 5
Gynaecological 19 12
Lung 11 7
Breast 30 20
Prostate 48 31
Testis 7 5
Other genitoiunnary tract 7 5
Haematological malignancies 10 7
Miscellaneous 7 3
aDifference between patients and reference group, P < 0.0001. bCo-mrbidity was unknown for ten patients.
general fatigue of the MFI was used as dependent variable and
general fatigue will be referred to as 'fatigue'. Pearson product
moment correlations and ANOVAs were used to assess bivariate.
concurrent associations. Stepwise regression analyses were used
for the multivariate prediction of general fatigue at follow-up.
using data from the pretreatment assessment as predictors. The
same grouping procedure was followed as described previously. as
were other analysis procedures conceming interactions. overlap in
item content and grouping on the basis ofradiation target area.
RESULTS
Sample
Disease-free patients
Of the original 250 participating patients. at the time of follow-up.
18 (7%7r) had died. 42 (17%7c) were excluded because of additional
cancer treatment during or following radiotherapy. eight (4%7)
could not be interviewed for logistic reasons. 13 (5%7) declined
further participation and 15 (6%e) had active disease. Socio-
demographic and clinical characteristics of the remaining, 154
(62%7c) patients without apparent disease are presented in Table 1.
Reference group
Of the 123 persons approached to complete the questionnaire. 106
(86%7) initially ag . Thirteen persons (12%) failed to comply.
resulting in a questionnaire sample of93 persons (74%). Ofthe 81
persons requested for an intenriew. 48 (59%) agreed to participate.
Two persons were subsequently excluded because they had a
history ofcancer. resulting in an 'interview' sample of46 persons.
Compan'son of the fatigue scores on the MFI of the interview
and questionnaire groups yielded no differences. The two groups
were therefore combined. Sociodemographic characteristics of the
final sample (n = 139) are included in Table 1.
Those respondents who refused participation were found to be
older (58 vs 46 years: F(l.166) = 14.11. P < 0.0005) and more
fatigued(mean5.5±2.3vs3.7±2.7:F(1.163)= 12.42.P<0.00l)
than participants. No difference was found with regard to gender
distribution.
Comparison ofpatients andreference group
The patient group contained more men (Z = -2.149. P < 0.01 ) and
was older [F(1.287) = 129.8. P < 0.0001)] than the reference
group. When controlling forage and gender distribution. no differ-
ences between the samples were found with respect to level of
education or prevalence ofco-morbiditv.
Course, dimensions and intensity of fatigue
In Table 2. the mean scores for the five dimensions of fatigue are
presented for the patients at follow-up and the reference group.
When controlling for age and gender. no differences in numerical
fatigue scores and in ceneral fatigue. physical fatigue. reduced
activity and reduced motivation were found between the two
samples. A trend emerged for mental fatigue. with the reference
group reporting more difficulties in cognitive functioninc
[F( 1.281) = 2.96. P = 0.08].
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Table 2 Mean scores for the five fatigue scales for disease-free patients
and general population (range 4-20)
Disease-tree patients General popultion
(n=154) (n=139)
Mean s.d. Mean s.d.
General fatigue 10.15 5.2 9.91 5.2
Physical fatigue 9.77 5.0 8.79 4.9
Reduced actvity 9.67 4.7 8.69 4.6
Reduced motivation 8.18 4.6 8.23 4.0
Mental fatigue 6.95 4.2 8.33 4.8
Characteristics of the fatigue experience
Frequency and intensity
About halfof the patients recalled hax ing been fatigued during the
first 3 months following radiotherapy (32%7 moderate and 19%/
verv much). whereas the remaining patients reported a bit (19%7c)
or no fatigue (30%). For 52%7 of the patients fatigue subsequently
decreased until it remained stable or completely' disappeared. 13
patients (10%e) reported a gradual increase in fatigue and another
eig,ht patients (5%7c) reported a return oftheir fatigue after an initial
decrease.
Fatigue after radiotherapy was not as bad as expected for 49%/
of the patients: 347 reported it to be worse than anticipated. For
39%7 of patients. fatiaue at follow-up was reported as one of the
three symptoms that caused them most distress and 26%7 expressed
some concern regyarding, their fatigaue. Fatigue correlated -0.45
(P < 0.001 ) with the patients' overall quality of life.
The following percentages are restricted to the patients w-ho
reported a fatigue score of greater than 1 on the numerical ratinc,
scale [90 patients (58%7) and 103 respondents from the reference
group (74%7,c)].
Time pattem
Seventy-four per cent of the patients reported no difference
between their current fatigue and fatigue in the previous month.
10%7 less intense fatigue and 16%7 more intense fatigue. In the
reference group. these percentages wvere 50%c. 16%7 and 34%7
respectively. Fatigue was generallv most intense in the evening for
24%7 of the patients: 39%7 could not identify a clear pattern. Of the
reference group. 2"2% was most fatigued in the late afternoon. 28%c
in the exening and 14% experienced no clear pattern.
Associatedsymptoms
The symptoms most frequently associated w-ith fatigue w-ere
sweating (28%7c) and shortness ofbreath (24%7c) in patients. and sore
muscles (37%7) and blurred siaht (28%7c) in the reference group.
Rest
Wlhen controlling for age. no significant differences between the
two samples in frequency and duration ofday-time napping. nor in
amount ofnight-time sleep appeared.
Associations with fatigue at follow-up
Results ofthe analyvses regardingy the concurrent. bivariate associa-
tions between fatigue and other factors at 9-month follow-up are
presented in Table 3. Women reported more fatigue than men. All
Table 3 Bivariate assocations with general fatigue for disease-free patients
(n = 154) 9 months after radiotherapy
Domains and their variables Statistic P
Sociodemographical
Sex F(1 150)=8.08 <0.01
Age r=-0.01 NS
Education F(3.148) = 2.11 NS
Medical
Diagnosis F(6.139) = 1.50 NS
Prognosis r= -0.07 NS
Co-morbidity F(1.140) = 3.43 0.07
Radiotherapy
Dose -0.18.0.16. -0.17a NS
Fractionation -0.07. 0.07. -0.13a NS
Physical
Physical distress r= 0.51 <0.001
Pain r= 0.40 <0.005
Quality of sleep r= 0.26 <0.001
Hours of sleep r= 0.24 <0.001
Day-time napping F(1,150) = 17.87 <0.0001
Performance status r= 0.55 <0.001
Psychological
Psychological distress r= 0.36 <0.001
Depression r= 0.49 <0.001
Optimism r= -0.10 NS
Neuroticism r= 0.11 NS
aForpatients radiated on the head and neck. thorax and abdomeri/peMs
respectively.
physical v-ariables were associated with fatigue. indicatiny more
faticue with a higher degree of phvsical distress. includinr pain.
and functional disabilitv. and a more impaired quality of sleep.
Patients slept more with increased levels of fatigue. both during
the dav and the nicht. Fatigue also increased with increasing levels
of psychological distress. No associations w-ere found w-ith
medical or treatment-related variables.
Prediction of fatigue 9 months after treatment
Results of the regression analy ses are presented in Table 4. Of the
sociodemographic characteristics (age. gender. education). only
gender explained 5% of the variance in fatigue of patients at
follow-up. None of the medical (diagnosis. progynosis. co-
morbiditv) or treatment-related (total radiation dose and fractiona-
tion) s-ariables predicted fatigrue at follow--up. Regarding the
domain of physical predictors of fatigue (physical distress. pain.
quality of sleep. fatigue and functional disability. all measured
pretreatment) the same interactions as discussed in the precedingy
paper were considered for inclusion in the regression analysis. but
again there kA-as no evidence supporting the hypotheses. and there-
fore interaction terms were not included. Pretreatment fatigyue. the
degree of functional disability and pain at that time explained
29%. 3%7 and 2%- of the variance in fatigue at follow-up respec-
tively. The same analysis. excluding pretreatment faticrue. resulted
in 22% ofthe variance in fatigue bein, explained by the degrree of
pretreatment functional disability only.
Regarding the psychological domain (neuroticism. optimism.
psychological distress and depression). the analysis (without inter-
actions) showed pretreatmentpsychologrical distress to explain 8%7
ofthe variance in fatigue at follow-up.
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Table 4 Significant pretreatment predictors of general fatigue scores at follow-up, using stepwise regression analyses
Domain Predictor R RI Regression coefficient
B s.e. B P
1 Sociodemographical Gender 0.23 0.05 2.38 0.84 <0.01
2 Physical Pretreatment fatigue 0.54 0.29 0.42 0.09 <0.0001
Functional disability 0.03 0.03 0.14 0.06 <0.05
Pain 0.02 0.02 -1.89 0.89 <0.05
2a Physical. not including pretreatment fatigue Functional disability 0.45 0.20 0.26 0.05 <0.0001
3 Psychological Psychological distress 0.27 0.08 0.39 0.12 <0.005
Combined (1.2,3) Pretreatment fatigue 0.55 0.30 0.41 0.09 <0.0001
Functonal disability 0.03 0.03 0.15 0.05 <0.01
Pain 0.02 0.04 -2.08 0.86 <0.05
Combined, not including Functional disability 0.47 0.22 0.26 0.05 <0.0001
pretreatment fatigue (1,2a,3)
A subsequent o erall regression analysis included the four
variables that significantly predicted fatigue within their separate
domains, taking their interrelatedness into account (see Table 4).
The degree of fatigue. functional disability and pain at pretreat-
ment contributed to the prediction of fatigue at follow-up.
explaining 30%7. 4%c and 3%7 of the variance respectively. When
pretreatment fatigue was not included. 22% of the variance in
outcome was explained by the degree ofpost-treatment functional
disability.
DISCUSSION
This is. to the best ofourknowledge. the first investigation that has
set out to investigate chronic fatigue in disease-free cancer
patients. The only related study was conducted by Bloom et al
(1990). who investigated energy expenditure in patients with
Hodgkin's disease 1-5 years after treatment.
The lack of difference in fatigue scores between disease-free
patients and the reference group is noteworthy because the former
group was expected to be more fatigued. Despite some resen-a-
tions. which will be discussed later. this finding challenges
the implicit assumption in studies on long-term effects that
complaints offatigue orlack ofenergy are characteristic for cancer
survivors. As described. high prevalence rates of complaints of
chronic fatigue are found in general population and primary
care studies as well. In addition. previous investigations that
included a non-cancer comparison group have also demonstrated
comparable fatigue ratings for cancerpatients and control subjects.
before (Irvine et al. 1994) or dunrng treatment (Pickard-Holley
1991: Glaus. 1993).
However. examination of the description of the fatigue experi-
ence does indicate some interesting differences between the two
samples. which show nuances in the apparent equivalence in
fatigue. More patients than respondents from the reference group
(74% vs 55%c) reported their fatigue to have been stable during the
month before assessment, suggesting fatigue to be a more chronic
condition in patients. Fatigue in patients also appears to be more
unpredictable, as indicated by the finding that 39% of patients
expenenced no clear pattern in the onset of their fatigue compared
with 14% of the reference group. The symptoms mostly associated
with fatigue also differ between the two samples: sweating and
shortness ofbreath in patients. painful muscles and bad sight in the
reference group. These findings suggest that maybe not the inten-
sity but the charactenrstics offatigue in cancer patients are different
from what is found in the general population. Glaus (1996) reached
a similar conclusion on the basis of a qualitative comparison ofthe
description of fatigue by cancer patients and healthy control
subjects.
Another resersation with respect to the finding of equivalent
fatigue scores in patients and the reference group is the problem of
.response shift'. The term response shift refers to the change in a
person's intemal standard for determining his or her level of
functioning on a given dimension (Breetvelt en van Dam. 1991:
Sprangers. 1996). The experience of fatigue dunrng radiotherapy
could have changed a patient's standard of measurement
concerning fatigue. What has been perceived to be 'intense'
fatigue before treatment, might be labelled 'slightly' fatigued after
having experienced exhaustion during treatment. The possible
occurrence of a response shift complicates the interpretation of
comparison data.
Finally. patients may himit their activities to such a degree that.
as a result, their fatigue does not exceed the level found in the
general population.
Our findings suggest that medical characteristics such as diag-
nosis, prognosis and co-morbidity. and treatment characteristics
such as total radiation dose. target area and fractionation are unre-
lated to long-term fatigrue. As indicated in the preceding article.
this lack of impact may result from the heterogeneity of the study
population and the crude assessment categories used.
The association between fatigue and psychological distress
found. both concurrently and prospectis-ely. is consistent wvith the
results from other research both in cancer (Nerenz et al. 1982:
Fobair et al. 1986: lamar. 1989: Blesh. 1991) and non-cancer
populations (Fisk et al. 1994: Fuhrer and Wessely. 1995: Belza.
1995). It underlines that the role of psychological distress should
be taken into account when trying to alleviate fatigue.
As in the treatment-related study. no association between
fatigue and neuroticism was found. This was unexpected. because
negative affectivity has been found to correlate consistently and
moderately with various measures of health complaints and
physical symptoms (Watson and Pennebaker. 1989). This findina
sugaests that fatigue reported by these patients cannot be consid-
ered to reflect agyeneral tendency to complain. The lack ofan asso-
ciation with optimism is more in line with the conclusion from
Watson (1988) that positive effect measures are aenerally, found to
be unrelated to self-reported health problems.
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Functional disability. fatigue and pain, assessed before the start
of treatment. together explained 37%/ of the -ariance in fatiaue at
follow-up. This is a considerable amount of -ariance explained
when takina into account that the variance in one symptom. more
than 9 months later is predicted. However. it also demonstrates
that it remains difficult to predict. on an individual basis. who w-ill
suffer from long-term fatigue.
The findings presented must be considered w-ithin the limita-
tions of this study. Our reference group was not necessarily an
unbiased sample of the Dutch general population. Respondents
were approached by means of telephone directories. which does
not cover individuals who lack a telephone or those with unlisted
numbers. Subjects who are registered tend to be more educated
than subjects w-ho are not (Brambilla and McKinlav. 1987). Also.
by being dependent on telephone contact. persons being more
frequently at home might be overrepresented. In view of the low
response rate in the interview sample. other selection processes
may also have affected the representativeness of this sample.
Respondents who refused to participate were found to be signifi-
cantly more fatioued than participants. As previously stated.
patients who refused study participation were also found to be
more tired than participants. As a result. the degree of fatigue of
both patients and the general population in this investigation might
be an underestimation ofthe problem.
Notw-ithstandin2 these limitations. the significant associations
found in this investigation between fatigue and both psychological
and physical variables again highlights that fatigue is a symptom
with multiple factors contributing, to its manifestation.
Consequently. a multidisciplinary approach seems warranted both
for its investigation and treatment. Physical therapists in particular
may offer a valuable contribution given the prominent role of
functional disability in the prediction offatigue.
Finally. one must beware of concluding that fatigue is a trivial
complaint. Concluding that cancer patients 9 months after radio-
therapy- seem not to differ from a population sample does not
imply that fatiorue is clinically irrelevant. More than a third of the
patients listed fatigue as one of the three symptoms causing them
most distress. it worried about a quarter of the patients and it was
negativelv and substantially related to the patient's evaluation of
their quality of life. These data indicate that fatigue can be a very
disturbing complaint.
REFERENCES
Belza BL 1995 Comparison of self-reported fatieue in rheumatoid arthritis and
controls. J Rheumarol 22: 639-44
Bensinz Al and Schreurs K 1995 Sexeserschillen bij moeheid (Gender differences
in fatigue . Huisarrs en I\erenschap 38: 412-421
Berglund G. Bolund C. Fornander T. Rutqvist LE and Sjoden P-O 1991 Late
effects ofadjus ant chemotherapy and postoperative radiotherapy on qualits of
life among breast cancer patients. Eur J Cancer 27: 1075-1081
Blesh K. Paice JA. Wickham R and Harten N. Sc-hnoor DK. Purl S. Rehs alt MI.
Lamm Kopp P. Manson S. Barrn Coveny S. McHale MI and Cahill 1 (1991
Correlates of fatigue in people %vith breast or lung cancer. Oncol Nurs Forum
18:81-87
Bloom JR Gors;k\ RD. Fobair P. Hoppe R. Cox RS. Varghese A and Spiegel D
1990( Ph\sIcal performance at work and at leisure: v-alidation of a measure of
bioloeical eneraN in survivors of Hod-kin's disease. J Pss chsoc Oncol 8:
49-63
Boven -%an K and DijksterhuiLzen P 1993 . De scharbare wt-aarde van aanvullend
onderc(o-ek in de huisartsprakijk. Thesis. Unix ersit\ of Amsterdam. Meditekst
Leli stad
Brambilla DJ and McKinla\ SM (1987) A comparison of responses to mailed
questionnaires and telephone interview-s in a mixed mode health sur-e\. .Am J
Epidemiol 126: 962-971
Breetv-elt IS and Dam FSAM van 1991 U Under reporting b! cancer patients: the
case of response-shift. Soi Sci Mfed 32: 981-987
Breij GCC and Visser-Wolf PJ De 1990s Investigarion Hodekin-Coniacrgr0up.
Research report. University of Utrecht
Chen MK (1986 The epidemiolog of self-percei\ed fatigaue among adults.
Preventive Med 15: 74-81
Devlen J. Maguire P. Philips P. Crowther D and Chambers H 1987 Psscholocical
problems associated with diagnosis and treatment of lNmphomas.
1. retrospecti e: 2. prospectise. BrMedJ295: 95 -957
Fisk JD. Pontefract A. Ritvo PG. Archibald CJ and Murra\ TJ i1994) The impact of
fatigue on patients with multiple selerosis. Can J.Neurol Sci 21: 9-14
Fobair P. Hoppe RT. Bloom J. Cox R. Vaughese A and Spiegel D 1986X
Pswchosocial problems among surnivors of Hodgkin s disease J Clin Oncol 4:
805
Fuhrer R and V%essel! S ( 1995 The epideemiolog, offatigue and depression: a
French primars-care studv. Psvchol .Med 25: 895-905
Glaus A (1993 * Assessment offatizue in cancer and non-cancer patients and in
health\ individuals. Support Care Cancer 1:-0 5-315
Glaus A. Crow R and Hammond S (1996( A qualitati-e stud\ to explore the concept
of fatizue/tiredness in cancer patients and in health% individuals. Support Care
Cancer 4: 82-96
Ir-ine D. Vincent L. Gravdon JE. Bubela N and Thompson L 1994( The presalence
and correlates of fatigue in patients receix ing treatment with chemotherap! and
radiotherap . Cancer Nursing 5: 367-378
Jamar S (1989( Fatisue in women receising chemotheraps for ox-anman cancer. In
Kev.4Ispects ofComfort. Management ofPain Fatigue and Nausea. Funk SG.
Tornquist EM. Campagne NMT. Archer Gopp L and Wiese RA (eds pp.
224-228. Springer Ness York
Kroenke K. Wood DR. Mangelsdorff AD. Meier N and Poss ell JB (1988( Chronic
fatigue in primar\ care. Prevalence. patient characteristics and outcome. J.45t4
260: 929-934
Leer JWH and Sc-hueren Van Der E (1996 Radiotherapeutic principles. In
Oncoloizv. van de Nelde CJH. Bosman FT and Wagener DTh (eds Bohn
Stafleu an Loghum. Houten/Die2em
Lesis G andWessel% SU1992'. The epidemiolog\ offatigue: more questions than
anssers. J Epidemiol Comm Health 46: 92-97
Nerenz DR. Leventhal H and Love RR (19821 Factors contributine to emotional
distress during cancer chemotheraps. Cancer50: 1020-1027
Pickard-Holle\ S (1991 Fatigue in canrcer patients. A descriptive studN. Cancer
Nursing 14: 13-19
Ray C (1991 Editorial: Chronic fatiaue syndrome and depression: conceptual and
methodological ambiguities. Psvchol.lfed21: 1-9
Rillsdale L (1991 flTired all the time. Br.ed J303: 1490-1491
Sharpe MI and Bass C 1992 Pathophysiological mechanisms in somatization.
IntRev Ps-vchiatr 4- 81-97
Smets EMA. Garssen B. Schuster-Uitterhoeve AU and De Haes JCIJM 1993(
Fatigue in cancer patients. BrJ Cancer 68: 220-224
Sprangers MAG (1996) Response-shift bias: a challenge to the assessment of
patients qualits- of life in cancer clinical trials. Cancer Treat Rev 22: 55-62
Valdini AF. Steinhardt SI and Jaffe AS (1987 Demographic correlates offatigue in a
uni ersirt familv health centre. Family- Practise 4: 10-107
Watson D and Pennebaker JW 1989 Health complaints. stress and distress.
Exploring the central role of negative affectivitr. Psvchol Rel 96 2% 42_5
Watson D. Clark- LA and Tellegen A (1988 Development and \alidation of brief
measures ofpositive and negative affect: the PA.NAS scales. J Pers S-c Psych
M:1063 1070
Wessel\ S. Butler S. Chalder T and Daxid A 1990( The co2nitixe behavioural
management of the postviral fatigue syndrome. In The Posrviral Fartiue
Sy-ndrome. Jenkins R and Mossbras Ji eds i. pp. 30-334. Wile\: Chichester
British Joumal of Cancer (1998) 78(7). 907-912 C Cancer Research Campaign 1998